Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Picard S, Titier K, Etienne G, Teilhet E, Ducint D, Bernard MA, Lassalle R, Marit G, Reiffers J, Begaud B, Moore N, Molimard M, Mahon FX. Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood 2006;109:3496-9. [PMID: 17192396 DOI: 10.1182/blood-2006-07-036012] [Citation(s) in RCA: 471] [Impact Index Per Article: 26.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open

For:	Picard S, Titier K, Etienne G, Teilhet E, Ducint D, Bernard MA, Lassalle R, Marit G, Reiffers J, Begaud B, Moore N, Molimard M, Mahon FX. Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood 2006;109:3496-9. [PMID: 17192396 DOI: 10.1182/blood-2006-07-036012] [Citation(s) in RCA: 471] [Impact Index Per Article: 26.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open

Number	Cited by Other Article(s)
451	Use of therapeutic drug monitoring in CML patients on imatinib. Blood 2007. [DOI: 10.1182/blood-2007-04-087874] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse
452	Tulliez M. Traitement de la leucémie myéloïde chronique en 2007. ACTA ACUST UNITED AC 2007. [DOI: 10.1016/s1773-035x(07)80394-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse
453	Blasdel C, Egorin MJ, Lagattuta TF, Druker BJ, Deininger MW. Therapeutic drug monitoring in CML patients on imatinib. Blood 2007;110:1699-701; author reply 1701. [PMID: 17712052 DOI: 10.1182/blood-2007-03-079871] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Adult Aged Antineoplastic Agents/administration & dosage Antineoplastic Agents/pharmacokinetics Benzamides Chromatography, High Pressure Liquid Female Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy Male Middle Aged Monitoring, Physiologic Piperazines/administration & dosage Piperazines/pharmacokinetics Pyrimidines/administration & dosage Pyrimidines/pharmacokinetics Remission Induction Collapse Grants HL082978-01 NHLBI NIH HHS Collapse Affiliation(s) Collapse
454	Sparreboom A. Unexplored Pharmacokinetic Opportunities with Microdosing in Oncology. Clin Cancer Res 2007;13:4033-4. [PMID: 17634525 DOI: 10.1158/1078-0432.ccr-07-0540] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Abstract Collapse Key Words Collapse MESH Headings Antineoplastic Agents/pharmacokinetics Antineoplastic Agents/therapeutic use Benzamides Dose-Response Relationship, Drug Humans Imatinib Mesylate Neoplasms/drug therapy Piperazines/pharmacokinetics Piperazines/therapeutic use Pyrimidines/pharmacokinetics Pyrimidines/therapeutic use Collapse Grants Collapse Affiliation(s) Collapse